Synthesis and evaluation of N-(3-oxo-2,3-dihydro-1H-pyrazol-4-yl)-1H-indole-carboxamides as cholecystokinin antagonists

Eric Lattmann*, Harjit Singh, Yodchai Boonprakob, Pornthip Lattmann, Jintana Sattayasai

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The structure-activity relationship optimization of the pyrazoline template 3a resulted in novel 3-oxo-1,2-diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-indole carboxamides 4a-4e. These non-peptidal CCK ligands have been shown to act as potent CCK 1 ligands in a [125]I-CCK-8 receptor binding assay. The best amides (4c and 4d) of this series displayed an IC50 of 20/25 CCK 1 for the CCK 1 receptor. In a subsequent in-vivo evaluation using various behaviour pharmacological assays, an anxiolytic effect of these novel 3-oxo-1,2-diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-indole carboxamides was found at high doses in the elevated plus-maze. In the despair swimming test, a model for testing antidepressants, an ED50 of 0.33/0.41 mg kg -1 was determined for amide 4c/4d and the antidepressant effect had a magnitude comparable to desimipramine. © 2006 The Authors.

Original languageEnglish
Pages (from-to)393-401
Number of pages9
JournalJournal of Pharmacy and Pharmacology
Issue number3
Publication statusPublished - Mar 2006


Dive into the research topics of 'Synthesis and evaluation of N-(3-oxo-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)-1<i>H</i>-indole-carboxamides as cholecystokinin antagonists'. Together they form a unique fingerprint.

Cite this